Half-dose thrombolytic therapy in patients with right heart thrombi
Authors:
- Jamal MoosaviJMJamal Moosavi
- Omid ShafeOSOmid Shafe
- Azin AlizadehaslAAAzin Alizadehasl
- Mozhgan ParsaeeMPMozhgan Parsaee
- Anita SadeghpourASAnita Sadeghpour
- Hamid Reza PouraliakbarHPHamid Reza Pouraliakbar
- Kiara Rezaei KalantariKKKiara Rezaei Kalantari
- Melody FarrashiMFMelody Farrashi
- Mehrdad Jafari FesharakiMFMehrdad Jafari Fesharaki
- Parham SadeghipourPSParham Sadeghipour
Open Access
- 30 May 2019
- journal article
- case report
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (7) , 3400-3407
Abstract
The management of floating right heart thrombi (FRHT) in patients with acute pulmonary emboli is controversial. Several recent case series have revealed similar efficacy and better survival rates with systemic thrombolytic therapy than with surgery. In this case series, we present our experience with the efficacy of “half-dose” or “safe-dose” thrombolytic therapy in the resolution of FRHT. Five patients who were admitted with confirmed acute pulmonary emboli and FRHT were included in the present report. Half-dose thrombolytic therapy (50 mg of alteplase) was administered to the patients. Follow-up echocardiography revealed complete resolution of the FRHT and considerable improvement in the right heart function. No bleeding events were recorded. Our small case series shows the efficacy and safety of half-dose thrombolytic therapy in FRHT resolution in a group of patients with high bleeding risk. Our findings should be tested in larger populations.Keywords
This publication has 17 references indexed in Scilit:
- Resolution of a Mobile Right Atrial Thrombus Complicating Acute Pulmonary Embolism With Low-Dose Tissue Plasminogen Activator in a Patient With Recent CraniotomyJournal of Intensive Care Medicine, 2016
- Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 PatientsThe Annals of Thoracic Surgery, 2015
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolismEuropean Heart Journal, 2014
- Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial HemorrhageJAMA, 2014
- Fibrinolysis for Patients with Intermediate-Risk Pulmonary EmbolismNew England Journal of Medicine, 2014
- Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial)The American Journal of Cardiology, 2013
- Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary ThromboembolismChest, 2010
- Effectiveness and Cost-effectiveness of Thrombolysis in Submassive Pulmonary EmbolismArchives of internal medicine (1960), 2007
- Free-Floating Thrombi in the Right HeartCirculation, 1999
- Efficacy of treatment of patients with echocardiographically detected right-sided heart thrombi: A meta-analysisAmerican Heart Journal, 1989